Upgrade to SI Premium - Free Trial

Lilly (LLY) Announces FDA Accepts NDA for Triple Combination Tablet for Adults with Type 2 Diabetes

June 4, 2019 7:31 AM
The U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for the investigational fixed-dose combination tablet ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Management Comments

Next Articles